Human cytomegalovirus UL97 kinase alters the accumulation of CDK1

Journal of General Virology

Volumn 93, Issue 8, 2012, Pages 1743-1755

  Gill, Rachel B ^a   James, Scott H ^b   Prichard, Mark N ^a,b  

^a Division of Cardiovascular Disease   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAVIR; CYCLIN DEPENDENT KINASE 1; PROTEIN KINASE UL97; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CELL EXPANSION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA REPLICATION; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LIFE CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VIRION; VIRUS REPLICATION;

CDC2 PROTEIN KINASE; CELL LINE; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN TRANSPORT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 84864039100     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.039214-0     Document Type: Article

References (84)

1. Anon. (2007). Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263. Drugs R D 8, 188-192.
2. L13 viral genes. J Virol 74, 8-15.
3. Advani, S. J., Weichselbaum, R. R. & Roizman, B. (2003a). Herpes simplex virus 1 activates cdc2 to recruit topoisomerase IIa for post-DNA synthesis expression of late genes. Proc Natl Acad Sci U S A 100, 4825-4830.
4. Advani, S. J., Weichselbaum, R. R. & Roizman, B. (2003b). Herpes simplex virus 1 activates cdc2 to recruit topoisomerase IIa for post-DNA synthesis expression of late genes. Proc Natl Acad Sci U S A 100, 4825-4830.
5. Arcangeletti, M. C., De Conto, F., Ferraglia, F., Pinardi, F., Gatti, R., Orlandini, G., Calderaro, A., Motta, F., Medici, M. C. & other authors (2003). Human cytomegalovirus proteins PP65 and IEP72 are targeted to distinct compartments in nuclei and nuclear matrices of infected human embryo fibroblasts. J Cell Biochem 90, 1056-1067.
6. Azzeh, M., Honigman, A., Taraboulos, A., Rouvinski, A. & Wolf, D. G. (2006). Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity. Virology 354, 69-79.
7. Baek, M.-C., Krosky, P. M., He, Z. & Coen, D. M. (2002). Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase. Importance of the P+5 position. J Biol Chem 277, 29593-29599.
8. Biron, K. K. (2006). Antiviral drugs for cytomegalovirus diseases. Antiviral Res 71, 154-163.
9. Biron, K. K., Harvey, R. J., Chamberlain, S. C., Good, S. S., Smith, A. A., III, Davis, M. G., Talarico, C. L., Miller, W. H., Ferris, R. & other authors (2002). Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother 46, 2365-2372.
10. Britt, W. (2008). Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol 325, 417-470.
11. Cano-Monreal, G. L., Tavis, J. E. & Morrison, L. A. (2008). Substrate specificity of the herpes simplex virus type 2 UL13 protein kinase. Virology 374, 1-10.
12. Cano-Monreal, G. L., Wylie, K. M., Cao, F., Tavis, J. E. & Morrison, L. A. (2009). Herpes simplex virus 2 UL13 protein kinase disrupts nuclear lamins. Virology 392, 137-147.
13. Caretti, G., Salsi, V., Vecchi, C., Imbriano, C. & Mantovani, R. (2003). Dynamic recruitment of NF-Y and histone acetyltransferases on cellcycle promoters. J Biol Chem 278, 30435-30440.
14. Chae, H.-D., Yun, J., Bang, Y.-J. & Shin, D. Y. (2004). Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions. Oncogene 23, 4084-4088.
15. Chevillotte, M., Landwehr, S., Linta, L., Frascaroli, G., Lü ske, A., Buser, C., Mertens, T. & von Einem, J. (2009). Major tegument protein pp65 of human cytomegalovirus is required for the incorporation of pUL69 and pUL97 into the virus particle and for viral growth in macrophages. J Virol 83, 2480-2490.
16. Chou, S. (2008). Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir. Rev Med Virol 18, 233-246.
17. Cinatl, J., Jr, Scholz, M. & Doerr, H. W. (2005). Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation. Med Res Rev 25, 167-185.
18. Cobbs, C. S., Soroceanu, L., Denham, S., Zhang, W. & Kraus, M. H. (2008). Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res 68, 724-730.
19. Dittmer, D. & Mocarski, E. S. (1997). Human cytomegalovirus infection inhibits G1/S transition. J Virol 71, 1629-1634.
20. Finch, J. S., Rosenberger, S. F., Martinez, J. D. & Bowden, G. T. (2001). Okadaic acid induces transcription of junB through a CCAAT box and NF-Y. Gene 267, 135-144.
21. Gill, R. B., Frederick, S. L., Hartline, C. B., Chou, S. & Prichard, M. N. (2009). Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir. Virol J 6, 9.
22. Goldberg, M. D., Honigman, A., Weinstein, J., Chou, S., Taraboulos, A., Rouvinski, A., Shinder, V. & Wolf, D. G. (2011). Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment. J Virol 85, 3375-3384.
23. Grahame-Clarke, C. (2005). Human cytomegalovirus, endothelial function and atherosclerosis. Herpes 12, 42-45.
24. Hamirally, S., Kamil, J. P., Ndassa-Colday, Y. M., Lin, A. J., Jahng, W. J., Baek, M.-C., Noton, S., Silva, L. A., Simpson-Holley, M. & other authors (2009). Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog 5, e1000275.
25. He, Z., He, Y. S., Kim, Y., Chu, L., Ohmstede, C., Biron, K. K. & Coen, D. M. (1997). The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol 71, 405-411.
26. Hertel, L. & Mocarski, E. S. (2004). Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of pseudomitosis independent of US28 function. J Virol 78, 11988-12011.
27. Hertel, L., Chou, S. & Mocarski, E. S. (2007). Viral and cell cycleregulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog 3, e6.
28. Hume, A. J., Finkel, J. S., Kamil, J. P., Coen, D. M., Culbertson, M. R. & Kalejta, R. F. (2008). Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320, 797-799.
29. Jault, F. M., Jault, J. M., Ruchti, F., Fortunato, E. A., Clark, C., Corbeil, J., Richman, D. D. & Spector, D. H. (1995). Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 69, 6697-6704.
30. Kalejta, R. F. (2008a). Functions of human cytomegalovirus tegument proteins prior to immediate early gene expression. Curr Top Microbiol Immunol 325, 101-115.
31. Kalejta, R. F. (2008b). Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev 72, 249-265.
32. Kalejta, R. F., Bechtel, J. T. & Shenk, T. (2003). Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 23, 1885-1895.
33. Kamil, J. P. & Coen, D. M. (2007). Human cytomegalovirus protein kinase UL97 forms a complex with the tegument phosphoprotein pp65. J Virol 81, 10659-10668.
34. Kawaguchi, Y. & Kato, K. (2003). Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2. Rev Med Virol 13, 331-340.
35. Kawaguchi, Y., Kato, K., Tanaka, M., Kanamori, M., Nishiyama, Y. & Yamanashi, Y. (2003). Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1d. J Virol 77, 2359-2368.
36. Krosky, P. M., Baek, M.-C. & Coen, D. M. (2003a). The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol 77, 905-914.
37. Krosky, P. M., Baek, M.-C., Jahng, W. J., Barrera, I., Harvey, R. J., Biron, K. K., Coen, D. M. & Sethna, P. B. (2003b). The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J Virol 77, 7720-7727.
38. Kuny, C. V., Chinchilla, K., Culbertson, M. R. & Kalejta, R. F. (2010). Cyclin-dependent kinase-like function is shared by the beta-and gamma-subset of the conserved herpesvirus protein kinases. PLoS Pathog 6, e1001092.
39. Kushnir, A. S., Davido, D. J. & Schaffer, P. A. (2010). Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter. J Virol 84, 188-200.
40. Lee, K. S., Asano, S., Park, J.-E., Sakchaisri, K. & Erikson, R. L. (2005). Monitoring the cell cycle by multi-kinase-dependent regulation of Swe1/Wee1 in budding yeast. Cell Cycle 4, 1346-1349.
41. Lee, C.-P., Huang, Y.-H., Lin, S.-F., Chang, Y., Chang, Y.-H., Takada, K. & Chen, M.-R. (2008). Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production. J Virol 82, 11913-11926.
42. Lindqvist, A., Rodri{dotless}́guez-Bravo, V. & Medema, R. H. (2009). The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 185, 193-202.
43. cdc2) promoter. Biochem Biophys Res Commun 246, 696-702.
44. Liu, J. & Kipreos, E. T. (2000). Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa. Mol Biol Evol 17, 1061-1074.
45. Lu, M. & Shenk, T. (1996). Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol 70, 8850-8857.
46. 2arrest. J Biol Chem 276, 5570-5576.
47. Marschall, M., Stein-Gerlach, M., Freitag, M., Kupfer, R., van den Bogaard, M. & Stamminger, T. (2001). Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97. J Gen Virol 82, 1439-1450.
48. Marschall, M., Stein-Gerlach, M., Freitag, M., Kupfer, R., van den Bogaard, M. & Stamminger, T. (2002). Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy. J Gen Virol 83, 1013-1023.
49. Marschall, M., Freitag, M., Suchy, P., Romaker, D., Kupfer, R., Hanke, M. & Stamminger, T. (2003). The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 311, 60-71.
50. Marschall, M., Marzi, A., aus dem Siepen, P., Jochmann, R., Kalmer, M., Auerochs, S., Lischka, P., Leis, M. & Stamminger, T. (2005). Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J Biol Chem 280, 33357-33367.
51. Michaelis, M., Doerr, H. W. & Cinatl, J. (2009). The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11, 1-9.
52. Michel, D., Pavić, I., Zimmermann, A., Haupt, E., Wunderlich, K., Heuschmid, M. & Mertens, T. (1996). The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J Virol 70, 6340-6346.
53. Miyazaki, T. & Arai, S. (2007). Two distinct controls of mitotic cdk1/ cyclin B1 activity requisite for cell growth prior to cell division. Cell Cycle 6, 1418-1425.
54. Ogg, S. C. & Lamond, A. I. (2002). Cajal bodies and coilin-moving towards function. J Cell Biol 159, 17-21.
55. Onishi, T., Zhang, W., Cao, X. & Hruska, K. (1997). The mitogenic effect of parathyroid hormone is associated with E2F-dependent activation of cyclin-dependent kinase 1 (cdc2) in osteoblast precursors. J Bone Miner Res 12, 1596-1605.
56. Padmanabhan, R., Tanimoto, A. & Sasaguri, Y. (2003). Transactivation of human cdc2 promoter by adenovirus E1A. Curr Top Microbiol Immunol 272, 365-397.
57. Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45.
58. Prichard, M. N. (2009). Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev Med Virol 19, 215-229.
59. Prichard, M. N., Gao, N., Jairath, S., Mulamba, G., Krosky, P., Coen, D. M., Parker, B. O. & Pari, G. S. (1999). A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol 73, 5663-5670.
60. Prichard, M. N., Britt, W. J., Daily, S. L., Hartline, C. B. & Kern, E. R. (2005). Human cytomegalovirus UL97 kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis. J Virol 79, 15494-15502.
61. Prichard, M. N., Keith, K. A., Quenelle, D. C. & Kern, E. R. (2006). Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections. Antimicrob Agents Chemother 50, 1336-1341.
62. Prichard, M. N., Sztul, E., Daily, S. L., Perry, A. L., Frederick, S. L., Gill, R. B., Hartline, C. B., Streblow, D. N., Varnum, S. M. & other authors (2008). Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J Virol 82, 5054-5067.
63. Rechter, S., Scott, G. M., Eickhoff, J., Zielke, K., Auerochs, S., Mü ller, R., Stamminger, T., Rawlinson, W. D. & Marschall, M. (2009). Cyclindependent kinases phosphorylate the cytomegalovirus RNA export protein pUL69 and modulate its nuclear localization and activity. J Biol Chem 284, 8605-8613.
64. Reeves, M. & Sinclair, J. (2008). Aspects of human cytomegalovirus latency and reactivation. Curr Top Microbiol Immunol 325, 297-313.
65. Rybak, R. J., Hartline, C. B., Qiu, Y.-L., Zemlicka, J., Harden, E., Marshall, G., Sommadossi, J.-P. & Kern, E. R. (2000). In vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infections. Antimicrob Agents Chemother 44, 1506-1511.
66. Salvant, B. S., Fortunato, E. A. & Spector, D. H. (1998). Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 72, 3729-3741.
67. Sanchez, V., Greis, K. D., Sztul, E. & Britt, W. J. (2000). Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J Virol 74, 975-986.
68. Sanchez, V., McElroy, A. K. & Spector, D. H. (2003). Mechanisms governing maintenance of Cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus. J Virol 77, 13214-13224.
69. Sanchez, V., Mahr, J. A., Orazio, N. I. & Spector, D. H. (2007). Nuclear export of the human cytomegalovirus tegument protein pp65 requires cyclin-dependent kinase activity and the Crm1 exporter. J Virol 81, 11730-11736.
70. Schmolke, S., Drescher, P., Jahn, G. & Plachter, B. (1995). Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: an unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport. J Virol 69, 1071-1078.
71. Smith-Donald, B. A., Durand, L. O. & Roizman, B. (2008). Role of cellular phosphatase cdc25C in herpes simplex virus 1 replication. J Virol 82, 4527-4532.
72. Stenberg, R. M., Depto, A. S., Fortney, J. & Nelson, J. A. (1989). Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J Virol 63, 2699-2708.
73. Thomas, M., Rechter, S., Milbradt, J., Auerochs, S., Mü ller, R., Stamminger, T. & Marschall, M. (2009). Cytomegaloviral protein kinase pUL97 interacts with the nuclear mRNA export factor pUL69 to modulate its intranuclear localization and activity. J Gen Virol 90, 567-578.
74. Tran, K., Kamil, J. P., Coen, D. M. & Spector, D. H. (2010). Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1. J Virol 84, 10832-10843.
75. van Zeijl, M., Fairhurst, J., Baum, E. Z., Sun, L. & Jones, T. R. (1997). The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 231, 72-80.
76. Varnum, S. M., Streblow, D. N., Monroe, M. E., Smith, P., Auberry, K. J., Pasa-Tolic, L., Wang, D., Camp, D. G., II, Rodland, K. & other authors (2004). Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78, 10960-10966.
77. Webel, R., Milbradt, J., Auerochs, S., Schregel, V., Held, C., Nö bauer, K., Razzazi-Fazeli, E., Jardin, C., Wittenberg, T. & other authors (2011). Two isoforms of the protein kinase pUL97 of human cytomegalovirus are differentially regulated in their nuclear translocation. J Gen Virol 92, 638-649.
78. Williams, S. L., Hartline, C. B., Kushner, N. L., Harden, E. A., Bidanset, D. J., Drach, J. C., Townsend, L. B., Underwood, M. R., Biron, K. K. & Kern, E. R. (2003). In vitro activities of benzimidazole D-and Lribonucleosides against herpesviruses. Antimicrob Agents Chemother 47, 2186-2192.
79. Williams-Aziz, S. L., Hartline, C. B., Harden, E. A., Daily, S. L., Prichard, M. N., Kushner, N. L., Beadle, J. R., Wan, W. B., Hostetler, K. Y. & Kern, E. R. (2005). Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro. Antimicrob Agents Chemother 49, 3724-3733.
80. Wolf, D. G., Courcelle, C. T., Prichard, M. N. & Mocarski, E. S. (2001). Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A 98, 1895-1900.
81. cdc2), cyclins A/B, and the tumor suppressor gene Rb in transformed cells by okadaic acid. J Cell Physiol 164, 424-433.
82. Yun, J., Chae, H.-D., Choi, T.-S., Kim, E.-H., Bang, Y.-J., Chung, J., Choi, K.-S., Mantovani, R. & Shin, D. Y. (2003). Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J Biol Chem 278, 36966-36972.
83. Zimmermann, A., Wilts, H., Lenhardt, M., Hahn, M. & Mertens, T. (2000). Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase. Antiviral Res 48, 49-60.
84. Zydek, M., Hagemeier, C. & Wiebusch, L. (2010). Cyclin-dependent kinase activity controls the onset of the HCMV lytic cycle. PLoS Pathog 6, e1001096.